中山肛门外有个小肉疙瘩不痛不痒中山从火车站到 百姓放心医院怎么走,中山市华都医院住院费用,中山看内痔医院,中山屁股拉出血怎么回事,中山痔疮脱垂,中山便血治疗医院排名,中山哪里外痔手术好

BEIJING, March 28 (Xinhuanet) -- Google Inc. is working with MasterCard Inc. and Citigroup Inc to develop a technology that could make mobile payments, according to media reports Monday.The new technology named "Nexus S Android" is embedded in Android mobile devices and allows customers to make purchases by waving their smartphones in front of a small reader at the checkout counter.Credit-card reader producer VeriFone Systems Inc, also involved in the new payment service, is developing contact-less devices that could allow people to pay with a wave or tap of credit card or a tap of smartphone.To use the service, holders of Citigroup-issued debit and credit cards must activate a mobile-payment application developed for one current model of Android phones. More models will be coming as the technology advances.Besides mobile payment, consumers would also be able to get targeted ads or discount offers, manage credit-card accounts and track spending through an application on their smartphones.Due to the deliberate design of the technology, customers have no need to worry about the security of their payment information. Nick Holland, a mobile-transactions analyst at Yankee Group, said the new technology is more sophisticated than credit cards with a magnetic stripe.With the coming service, Google is aiming to boost its advertising business by offering retailers more data about their customers and help them target ads and discount offers to mobile-device users near their stores.An insider told that Google was not expected to get a cut of the transaction fees.The service is expected to be released this year. Once released, it will broaden the uses of smartphones for everyday activities—from chatting to emailing to shopping.

XI'AN, March 31 (Xinhua) -- Archeologists in the northwestern Shaanxi Province confirmed Thursday, after weeks of lab work, that the bones they found in a bronze cooking vessel from a 2,400-year-old tomb belonged to a male dog under a year old.Altogether 37 bones were found in the cooking vessel, which was unearthed in November 2010 from a tomb near the Xianyang International Airport in the suburbs of Xi'an, said Liu Daiyun, a researcher with the Shaanxi Provincial Archeological Institute."When we opened the 20-cm tall cooking vessel, we were shocked to find bones and soup inside," said Liu.The bones and soup had all turned greenish, similar in color to the bronze container, he said.Cooking vessels were a typical offering Chinese once presented to their deceased ancestors, said Liu.The custom became prevalent around the Warring States Period (475 - 221 BC), the time Liu and his colleagues believed this dog stew was offered.Hu Songmei, a researcher who did most of the lab work to identify the bones, said they found the bones were "strikingly similar" to four complete sets of canine skeletons preserved at the institute's lab.The newly found bones, however, were smaller, indicating the dog was just a pup, said Hu.Hu said further lab work was needed to tell the exact species of the canine. "Dogs were domesticated by humans at least 10,000 years ago, but the early dog species that evolved from wild wolves could be very different from today's pet dogs."Besides the dog bones, experts also found a wine-like liquid in another airtight kitchen ware from the same tomb. "Whoever the tomb owner was, he must have loved liquor and meat, so his sons wished he could still enjoy the feast in his grave."

BEIJING, March 29 (Xinhuanet) -- Tickets for Apple's annual World Wide Developer Conference (WWDC) 2011 have already been sold out ten hours after the event was announced Monday, according to media reports.It is the first time the event sold out the same day it was announced. Last year, the conference sold out in eight days.WWDC 2011, with the tickets priced at 1599 U.S. dollars, will run from June 6 till June 10 at the Moscone West conference center in San Francisco.This year's speedy turnaround is probably because of a rumored double-focus on iOS and Mac OS."At this year's conference we are going to unveil the future of iOS and Mac OS," Philip Schiller, Apple's senior vice president of Worldwide Product Marketing, said in a press release."If you are an iOS or Mac OS X software developer, this is the event that you do not want to miss."The event will feature more than 100 technical sessions presented by Apple engineers on Application Frameworks; Graphics, Media and Games; Developer Tools; Internet and Web, and Core OS.

LOS ANGELES, May 23 (Xinhua) -- NASA's Gravity Recovery And Interior Laboratory spacecraft (Grail) will begin final preparations for a launch on a Moon mission in late summer, the Jet Propulsion Laboratory (JPL) said on Monday.The dynamic duo will orbit the moon to determine the structure of the lunar interior from crust to core and to advance understanding of the thermal evolution of the moon, according to JPL in Pasadena, Los Angeles.After arriving at the Astrotech payload processing facility in Titusville, Florida last week, the Grail twins, known as Grail-A and Grail-B, were removed from their shipping containers Monday. Later this week, they will begin functional testing to verify their state of health, said JPL.The twins were shipped from Lockheed Martin Space Systems, Denver.Over the next four months at the Astrotech facility, the spacecraft will undergo final testing, fueling and packaging in the shroud that will protect them as the Delta II launch vehicle lifts them into space. The spacecraft will then be transported to the Cape Canaveral Air Force Station for installation atop the rocket that will carry them toward the moon, JPL said."We're only a few full moons away from a mission that will reveal clues not only into the history of the moon and Earth, but will provide important data for future lunar exploration," said Maria Zuber, Grail's principal investigator, based at the Massachusetts Institute of Technology.Grail will be carried into space aboard a United Launch Alliance Delta II Heavy rocket lifting off from Launch Complex-19 at the Cape Canaveral Air Force Station in Florida. The launch period opens Sept. 8, 2011, and extends through Oct. 19. For a Sept. 8 liftoff, the launch window opens at 5:37 a.m. PDT (8:37 a.m. EDT) and remains open through 6:16 a.m. PDT (9:16 a.m. EDT).Grail-A and Grail-B will fly in tandem orbits around the moon for several months to measure its gravity field in unprecedented detail.The mission will also answer longstanding questions about Earth' s moon, and provide scientists a better understanding of how Earth and other rocky planets in the solar system formed, according to JPL, which manages the Grail mission.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.